Better-than-expected HRT growth drives substantial increases in Recruit's earnings forecasts and target price

Overview

Following Recruit's release of first-quarter FY3/27 results and increase in full-year guidance, this report reassesses its HRT growth, margins, long-term addressable market, and valuation. Citi believes the strong performance of US HRT is not merely a short-term profit contributor and that Indeed's functional evolution may also expand its service scope. It therefore raises its multiyear earnings forecasts and DCF target price while reiterating its Buy rating.

Core views

Both the first-quarter results and the company's revised guidance represented positive surprises. Recruit's first-quarter revenue reached ¥1.05 trillion, up 19% YoY, while operating profit was ¥255.4 billion, up 66% YoY, with both growth and profitability exceeding expectations. The high-margin HRT business accelerated markedly, with revenue reaching $2.85 billion, up 21% YoY, driven by particularly strong performance in the US and in Europe and other regions. US HRT revenue increased 30% YoY, significantly exceeding Citi's prior expectations. HRT's EBITDA+S margin rose to 47.4%, making it the main driver of consolidated profit growth. Based on the first-quarter performance, the company raised its FY3/27 revenue guidance from ¥4.03 trillion to ¥4.23 trillion and its operating profit guidance from ¥787 billion to ¥945 billion, with the revisions mainly reflecting an improved HRT outlook. The additional ¥200 billion of revenue corresponds to approximately ¥160 billion of additional operating profit, reflecting HRT's exceptionally high incremental margin: most incremental revenue can be converted into profit rather than being fully absorbed by additional costs. Accordingly, Citi raised its FY3/27 US HRT revenue growth assumption from 16% to 27%. Company guidance implies 25% growth in US HRT sales and 30% growth in US revenue per job posting (ARPJ), while Citi's model assumes 27% and 31%, respectively. Citi expects overall FY3/27 HRT revenue of ¥1.8 trillion, up 26% YoY. Although it assumes growth will gradually decelerate from FY3/28 onward, actual growth could be revised upward again if Indeed's product evolution proceeds faster than expected. Consolidated forecasts were also raised substantially. Citi now expects FY3/27 revenue of ¥4.231 trillion, up 14.4% YoY; operating profit of ¥973.811 billion, up 54.4% YoY; and an operating margin of 23.0%. Net profit is forecast at ¥801.011 billion, up 61.2% YoY, with EPS of ¥573.7. FY3/28 revenue, operating profit, and net profit are expected to reach ¥4.656 trillion, ¥1.222 trillion, and ¥1.061 trillion, respectively; for FY3/29, they are expected to reach ¥5.096 trillion, ¥1.546 trillion, and ¥1.408 trillion, respectively. The corresponding adjusted EBITDA margin is expected to rise from 20.0% in FY3/26 to 25.6% in FY3/27, 28.7% in FY3/28, and 32.7% in FY3/29. The report concludes that even if revenue growth moderates after FY3/27, profit can continue growing at a double-digit rate. The margin expansion thesis is based on the combined effects of business mix and cost efficiency. The report's adjusted EBITDA measure, or “EBITDA+S,” adds share-based compensation back to EBITDA. HRT has high incremental margins, and an increase in its revenue contribution and scale can rapidly lift consolidated margins. At the same time, improved matching efficiency and greater cost efficiency further strengthen operating leverage. Citi expects longer-term profit growth to be supported by HRT expansion and margin improvement in the MMT business. Indeed's functional evolution is central to the long-term growth thesis. The report believes improved matching quality will allow Indeed to move beyond the $34 billion recruitment advertising and talent-search tools market and enter the $71 billion staffing intermediary market, represented by direct recruitment services. Combining the two would expand the addressable market from $34 billion to $105 billion, providing roughly three times the original growth opportunity. Accordingly, Citi expects HRT revenue to reach ¥3.1 trillion in FY3/31, equivalent to 2.1 times FY3/26 revenue. The valuation continues to use DCF, with the methodology and key parameters unchanged; the target-price increase is entirely attributable to higher earnings and free-cash-flow forecasts. The model uses detailed earnings forecasts for FY3/27–FY3/31 and assumes an 8% sales CAGR for FY3/32–FY3/35. It uses a beta of 1.3, a terminal growth rate of 2.0%, a risk-free rate of 2.0%, an equity risk premium of 5.2%, and a WACC of 8%. On this basis, Citi raises its target price from ¥14,000 to ¥20,000. Relative to the current price of ¥15,900.0 on August 21, 2026, the report indicates expected share-price upside of 25.8%; including an expected dividend yield of 0.2%, expected total return is 25.9%. The report's scenario analysis also examines cases in which free cash flow is 25% above and 50% below the base case. In the near term, Citi adds an upside Catalyst Watch with a 90-day horizon. Indeed plans to hold its FutureWorks customer event on September 2–3, 2026, where it will announce service technologies and features under development. With HRT growth already accelerating, the report believes these announcements could serve as share-price catalysts. Citi also expects second-quarter earnings to remain strong and views a bottoming in US recruitment advertising volumes as another near-term catalyst. The medium- to long-term thesis also includes a recovery in recruitment advertising volumes as the US labor market improves, growth in revenue per advertisement, expansion of Indeed's functionality, and improvement in MMT margins. The report explicitly identifies four downside risks: a rapid deterioration in the macroeconomic environment that causes Indeed to perform below expectations; upfront investment costs associated with the HRT recovery that are significantly higher than expected; saturation in Japan's domestic market that slows MMT growth; and unexpected asset impairment losses. Any of these factors could cause the share price to remain significantly below Citi's target price.

Analysis framework

Citi first compares first-quarter revenue, profit, US HRT growth, and margins with its own expectations. It then combines the company's revised FY3/27 guidance with subsequent discussions with management to reset its US HRT and consolidated earnings forecasts. The report subsequently uses HRT's high incremental margin to explain how incremental revenue translates into consolidated margin expansion and constructs a long-term revenue trajectory based on an addressable-market analysis covering both recruitment advertising and staffing intermediary markets accessible to Indeed. Finally, it incorporates the updated earnings and free-cash-flow forecasts into a DCF model with unchanged parameters and assesses valuation sensitivity and near-term drivers through upside and downside free-cash-flow scenarios and 90-day catalyst events.

Methodology notes

• Valuation methodologyDCF discounted cash flow

  DCF valuation

  The report discounts expected free cash flow for FY3/27–FY3/35 to present value and adds a terminal value to determine the ¥20,000 target price. Higher earnings forecasts with unchanged valuation parameters are the direct reason for this target-price increase.

• Company fundamentals and financial frameworkOperating/financial leverage analysis

  HRT's high incremental margin and consolidated margin expansion

  The report demonstrates that HRT revenue growth can translate more rapidly into consolidated profit by showing that ¥200 billion of additional revenue generates approximately ¥160 billion of additional operating profit and that HRT's EBITDA+S margin rose to 47.4%.

• Industry/sector analysis framework

  Total addressable market (TAM) expansion analysis

  The report expands Indeed's serviceable market from the $34 billion recruitment advertising and tools market to $105 billion by adding the $71 billion staffing intermediary market, supporting the argument that functional evolution could create roughly three times the long-term growth opportunity.

• Valuation methodology

  Free-cash-flow bull, base, and bear scenario analysis

  The report examines cases in which free cash flow is 25% above and 50% below the base case to demonstrate the valuation's sensitivity to deviations in long-term cash flow.

• Event trading and behavioral financeEvent-driven analysis

  90-day upside Catalyst Watch

  The report identifies Indeed FutureWorks product and technology announcements and second-quarter results that are expected to remain strong as specific events that could drive the share price higher within 90 days.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Recruit Holdings (6098.T)

  Citi views accelerating HRT revenue, expansion of Indeed's functionality, improved matching efficiency, and higher MMT margins as the principal drivers of earnings and valuation upside.

  Strengths

  High HRT incremental margins, a strong foundation for the Indeed business, an expanding addressable market, and the ability to respond flexibly to changes in the operating environment.

  Weaknesses

  US recruitment advertising volumes remain affected by a weak labor market, while MMT faces long-term saturation in Japan's domestic market.

  Comparison

  The report does not provide a direct comparison with specific peers.

  Risks

  Macroeconomic deterioration, weaker-than-expected Indeed performance, overspending on HRT recovery investments, slower MMT growth, and unexpected impairments could all reduce earnings and valuation.

Key data

• First-quarter revenue¥1.05 trillionUp 19% YoY, exceeding expectations
• First-quarter operating profit¥255.4 billionUp 66% YoY, exceeding expectations
• HRT first-quarter revenue$2.85 billionUp 21% YoY
• US HRT first-quarter revenue growth+30% YoYSignificantly above Citi's expectations
• HRT EBITDA+S margin47.4%High incremental margins drive consolidated earnings
• FY3/27 company revenue guidance¥4.23 trillionRaised from ¥4.03 trillion
• FY3/27 company operating profit guidance¥945 billionRaised from ¥787 billion
• FY3/27 US HRT growth assumption27%Citi's previous assumption was 16%; company guidance is 25%
• FY3/27 US ARPJ growth forecast31%Company guidance is 30%
• FY3/27 HRT revenue forecast¥1.8 trillionUp 26% YoY
• FY3/31 HRT revenue forecast¥3.1 trillionEquivalent to 2.1 times FY3/26
• Indeed addressable market$105 billionComprising the $34 billion recruitment advertising and tools market plus the $71 billion staffing intermediary market
• Citi FY3/27 operating profit forecast¥973.811 billionUp 54.4% YoY, with an operating margin of 23.0%
• Citi FY3/27 net profit forecast¥801.011 billionUp 61.2% YoY, with EPS of ¥573.7
• Key DCF parametersbeta 1.3; terminal growth rate 2.0%; risk-free rate 2.0%; equity risk premium 5.2%; WACC 8%Parameters are unchanged; the target-price increase results from higher forecast cash flow
• Target price and current price¥20,000; ¥15,900.0Target price raised from ¥14,000; current price as of August 21, 2026, 15:30
• Expected total return25.9%Includes expected share-price upside of 25.8% and an expected dividend yield of 0.2%

Impact & implications

The report believes that better-than-expected HRT growth not only raises the FY3/27 earnings base but will also drive consolidated margin expansion over the coming years through high incremental margins. If improvements in Indeed's matching quality and functionality allow the company to enter the staffing intermediary market, HRT's long-term revenue ceiling could rise significantly, with the updated cash-flow forecasts supporting a higher DCF target price. In the near term, product announcements, second-quarter earnings, and a bottoming in US recruitment advertising volumes could cause this fundamental thesis to be reflected in the share price more quickly.

Risks

• A rapid deterioration in the macroeconomic environment could cause Indeed to perform more weakly than Citi expects.
• The recovery of the HRT business could entail upfront investment costs significantly above expectations.
• Saturation in Japan's domestic market could slow growth in the MMT business.
• The company could recognize unexpected asset impairment losses.

What to watch

• Monitor Indeed's FutureWorks event on September 2–3, 2026, and its announcements regarding service technologies and new features.
• Monitor whether second-quarter FY3/27 earnings can sustain the strong performance recorded in the first quarter.
• Monitor whether US recruitment advertising volumes bottom out and begin to recover as the labor market improves.
• Monitor whether US HRT sales growth and ARPJ can reach Citi's forecasts of 27% and 31%, respectively.
• Monitor whether improvements in Indeed's matching quality and functional evolution can accelerate its entry into the broader staffing intermediary market.
• Monitor whether HRT's high incremental margins and improved cost efficiency can continue driving consolidated EBITDA margin expansion.